Introduction of anti-tumor necrosis factor alpha (anti-TNFα) therapy for rheumatic disease has revolutionized disease control and greatly improved the outcome of rheumatic disease (Mewar and Wilson 2011). The gene discussed is TNF; the disease is rheumatic disorder.